Nanoparticle-based drug delivery <i>via</i> RBC-hitchhiking for the inhibition of lung metastases growth
Ivan V. Zelepukin(Uppsala University), Maxim P. Nikitin(Russian Academy of Sciences), Victoria O. Shipunova(Institute of Bioorganic Chemistry), Andrey Babenyshev(Moscow Institute of Physics and Technology), Petr I. Nikitin(Russian Academy of Sciences), Irina V. Balalaeva(N. I. Lobachevsky State University of Nizhny Novgorod), Sergey M. Deyev(Institute of Bioorganic Chemistry), Alexey V. Yaremenko(Brigham and Women's Hospital)
Cited by 180
Related Papers
Cancer nanomedicine toward clinical translation: Obstacles, opportunities, and future prospects
|Med|2022|222
Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery
|Nature Communications|2024|162
Enhancement of the blood-circulation time and performance of nanomedicines via the forced clearance of erythrocytes
|Nature Biomedical Engineering|2020|146
Oral drug delivery platforms for biomedical applications
|Materials Today|2023|123